Author/Creator: Lin, Hollis - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Lin, Hollis

1. An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy. (4th March 2019)

Authors:: Planté-Bordeneuve, Violaine; Lin, Hollis; Gollob, Jared; Agarwal, Sonalee; Betts, Marissa; Fahrbach, Kyle; Chitnis, Madhura; Polydefkis, Michael
Journal:: Expert opinion on pharmacotherapy
Issue:: Volume 20:Number 4(2019)
Page Start:: 473
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data. (September 2019)

Authors:: Brandman, Danielle; Lin, Hollis; McManus, Anastasia; Agarwal, Sonalee; Gache, Larry M.; Irish, William; Gollob, Jared; Živković, Saša A
Journal:: Progress in transplantation
Issue:: Volume 29:Number 3(2019)
Page Start:: 213
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy. (2nd January 2021)

Authors:: Gorevic, Peter; Franklin, Jaclyn; Chen, Jihong; Sajeev, Gautam; Wang, Jessie C. H.; Lin, Hollis
Journal:: Expert opinion on pharmacotherapy
Issue:: Volume 22:Number 1(2021)
Page Start:: 121
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Patient Factors Contributing to Variation in Same-Hospital Readmission Rate. (June 2015)

Authors:: Henke, Rachel Mosher; Karaca, Zeynal; Lin, Hollis; Wier, Lauren M.; Marder, William; Wong, Herbert S.
Journal:: Medical care research and review
Issue:: Volume 72:Number 3(2015:Jun.)
Page Start:: 338
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Response to the letter to the editor on "an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy". (13th August 2019)

Authors:: Lin, Hollis; Agarwal, Sonalee; Betts, Marissa; Fahrbach, Kyle; Chitnis, Madhura; Polydefkis, Michael
Journal:: Expert opinion on pharmacotherapy
Issue:: Volume 20:Number 12(2019)
Page Start:: 1529
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. S3155 Impact of Patisiran, an RNAi Therapeutic, on Diarrhea Symptoms in Patients With Hereditary Transthyretin-Mediated Amyloidosis. (October 2020)

Authors:: Obici, Laura; Gonzalez-Duarte, Alejandra; Waddington-Cruz, Marcia; Lin, Hollis; Merkel, Madeline; Wang, Yue; Ueda, Mitsuharu
Journal:: American journal of gastroenterology
Issue:: Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1
Page Start:: S1657
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗